• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于长期新冠患者和非长期新冠患者的贝叶斯生存分析:一项使用国家新冠队列协作组(N3C)数据的队列研究。

A Bayesian Survival Analysis on Long COVID and non Long COVID patients: A Cohort Study Using National COVID Cohort Collaborative (N3C) Data.

作者信息

Jiang Sihang, Loomba Johanna, Zhou Andrea, Sharma Suchetha, Sengupta Saurav, Liu Jiebei, Brown Donald

机构信息

School of Engineering and Applied Science, University of Virginia, 351 McCormick Rd, Charlottesville, 22904, VA, United States.

integrated Translational Health Research Institute of Virginia (iTHRIV), University of Virginia, 560 Ray C. Hunt Drive, Charlottesville, 22903, VA, United States.

出版信息

medRxiv. 2024 Jun 25:2024.06.25.24309478. doi: 10.1101/2024.06.25.24309478.

DOI:10.1101/2024.06.25.24309478
PMID:38978664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11230301/
Abstract

Since the outbreak of COVID-19 pandemic in 2020, numerous researches and studies have focused on the long-term effects of COVID infection. The Centers for Disease Control (CDC) implemented an additional code into the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) for reporting 'Post COVID-19 condition, unspecified (U09.9)' effective on October 1st 2021, representing that Long COVID is a real illness with potential chronic conditions. The National COVID Cohort Collaborative (N3C) provides researchers with abundant electronic health records (EHR) data by aggregating and harmonizing EHR data across different clinical organizations in the United States, making it convenient to build up a survival analysis on Long COVID patients and non Long COVID patients among large amounts of COVID positive patients.

摘要

自2020年新冠疫情爆发以来,众多研究都聚焦于新冠感染的长期影响。美国疾病控制中心(CDC)在《国际疾病分类第十次修订本,临床修订版》(ICD-10-CM)中新增了一个代码,用于报告“未特指的新冠后状况(U09.9)”,该代码于2021年10月1日起生效,这表明新冠长期症状是一种伴有潜在慢性病的真实疾病。美国国家新冠队列协作组织(N3C)通过整合和协调美国不同临床机构的电子健康记录(EHR)数据,为研究人员提供了丰富的EHR数据,便于在大量新冠阳性患者中对新冠长期症状患者和非新冠长期症状患者进行生存分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/6dc8ddc7e1f9/nihpp-2024.06.25.24309478v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/ae87f71155af/nihpp-2024.06.25.24309478v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/b550e6acd72c/nihpp-2024.06.25.24309478v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/6dc8ddc7e1f9/nihpp-2024.06.25.24309478v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/ae87f71155af/nihpp-2024.06.25.24309478v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/b550e6acd72c/nihpp-2024.06.25.24309478v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5181/11230301/6dc8ddc7e1f9/nihpp-2024.06.25.24309478v1-f0003.jpg

相似文献

1
A Bayesian Survival Analysis on Long COVID and non Long COVID patients: A Cohort Study Using National COVID Cohort Collaborative (N3C) Data.一项关于长期新冠患者和非长期新冠患者的贝叶斯生存分析:一项使用国家新冠队列协作组(N3C)数据的队列研究。
medRxiv. 2024 Jun 25:2024.06.25.24309478. doi: 10.1101/2024.06.25.24309478.
2
A Bayesian Survival Analysis on Long COVID and Non-Long COVID Patients: A Cohort Study Using National COVID Cohort Collaborative (N3C) Data.长新冠患者与非长新冠患者的贝叶斯生存分析:一项使用国家新冠队列协作组(N3C)数据的队列研究
Bioengineering (Basel). 2025 May 7;12(5):496. doi: 10.3390/bioengineering12050496.
3
Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.新冠后定义及临床编码实践的特征描述:纵向研究
Online J Public Health Inform. 2024 May 3;16:e53445. doi: 10.2196/53445.
4
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.国家 COVID 队列协作组织(N3C):原理、设计、基础设施和部署。
J Am Med Inform Assoc. 2021 Mar 1;28(3):427-443. doi: 10.1093/jamia/ocaa196.
5
Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US.美国常规临床实践中 COVID-19 诊断后后遗症编码的使用。
JAMA Netw Open. 2022 Oct 3;5(10):e2235089. doi: 10.1001/jamanetworkopen.2022.35089.
6
Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based Cohort Study From the RECOVER Program.在糖尿病成人中普遍使用二甲双胍与长新冠的发病率:来自 RECOVER 计划的基于电子健康记录的队列研究。
Diabetes Care. 2024 Nov 1;47(11):1930-1940. doi: 10.2337/DCa24-0032.
7
Coding long COVID: characterizing a new disease through an ICD-10 lens.长新冠编码:通过 ICD-10 视角描述一种新疾病。
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
8
Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.ICD-10 编码 U09.9 的记录率和退伍军人事务部患有新冠后状况患者的临床特征。
JAMA Netw Open. 2023 Dec 1;6(12):e2346783. doi: 10.1001/jamanetworkopen.2023.46783.
9
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program.电子健康记录队列中与新冠病毒急性后遗症相关的风险因素:作为美国国立卫生研究院康复计划一部分的全国新冠队列协作研究(N3C)分析
medRxiv. 2022 Aug 17:2022.08.15.22278603. doi: 10.1101/2022.08.15.22278603.
10
Coding Long COVID: Characterizing a new disease through an ICD-10 lens.对长期新冠进行编码:通过国际疾病分类第十版(ICD - 10)来界定一种新疾病。
medRxiv. 2022 Sep 2:2022.04.18.22273968. doi: 10.1101/2022.04.18.22273968.

本文引用的文献

1
Coding long COVID: characterizing a new disease through an ICD-10 lens.长新冠编码:通过 ICD-10 视角描述一种新疾病。
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
2
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes.可泛化的长新冠亚型:来自 NIH N3C 和 RECOVER 项目的发现。
EBioMedicine. 2023 Jan;87:104413. doi: 10.1016/j.ebiom.2022.104413. Epub 2022 Dec 21.
3
Survival After Severe COVID-19: Long-Term Outcomes of Patients Admitted to an Intensive Care Unit.严重 COVID-19 后的存活情况:入住重症监护病房患者的长期结局。
J Intensive Care Med. 2022 Aug;37(8):1019-1028. doi: 10.1177/08850666221092687. Epub 2022 Apr 5.
4
COVID-19 Survival and its impact on chronic kidney disease.COVID-19 患者的生存情况及其对慢性肾脏病的影响。
Transl Res. 2022 Mar;241:70-82. doi: 10.1016/j.trsl.2021.11.003. Epub 2021 Nov 10.
5
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.国家 COVID 队列协作组织(N3C):原理、设计、基础设施和部署。
J Am Med Inform Assoc. 2021 Mar 1;28(3):427-443. doi: 10.1093/jamia/ocaa196.
6
Mortality and survival of COVID-19.COVID-19 的死亡率和生存率。
Epidemiol Infect. 2020 Jun 25;148:e123. doi: 10.1017/S0950268820001405.
7
Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.在生存数据分析中忽略竞争事件可能会导致有偏的结果:竞争风险分析的非数学说明。
J Clin Epidemiol. 2020 Jun;122:42-48. doi: 10.1016/j.jclinepi.2020.03.004. Epub 2020 Mar 9.
8
Where to look for the most frequent biases?在哪里寻找最常见的偏倚?
Nephrology (Carlton). 2020 Jun;25(6):435-441. doi: 10.1111/nep.13706. Epub 2020 Mar 27.
9
Charlson Comorbidities Index.查尔森合并症指数
J Physiother. 2016 Jul;62(3):171. doi: 10.1016/j.jphys.2016.05.008. Epub 2016 Jun 11.
10
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.